159 related articles for article (PubMed ID: 34003534)
21. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
[TBL] [Abstract][Full Text] [Related]
22. SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling.
Wilczek Y; Sachdeva A; Turner H; Veeratterapillay R
Ann R Coll Surg Engl; 2021 Jan; 103(1):e20-e22. PubMed ID: 32969237
[TBL] [Abstract][Full Text] [Related]
23. Succinate dehydrogenase deficient renal cell carcinoma: A case report of an uncommon renal cancer.
Kodare D; Menon S; Prakash G; Desai S
Indian J Cancer; 2023 Oct; 60(4):583-585. PubMed ID: 38189645
[TBL] [Abstract][Full Text] [Related]
24. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
Wang G; Rao P
Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
[TBL] [Abstract][Full Text] [Related]
25. Hand-Assisted Laparoscopic Partial Nephrectomy for Large Renal Carcinoma with Succinate Dehydrogenase Deficiency.
Bersang AB; Bube S; Fode M; Azawi NH
J Endourol Case Rep; 2018; 4(1):12-14. PubMed ID: 29450259
[No Abstract] [Full Text] [Related]
26. Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis.
Ricci L; Stanley FU; Eberhart T; Mainini F; Sumpton D; Cardaci S
Cell Death Dis; 2023 Jul; 14(7):403. PubMed ID: 37414778
[TBL] [Abstract][Full Text] [Related]
27. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
Fuchs TL; Maclean F; Turchini J; Vargas AC; Bhattarai S; Agaimy A; Hartmann A; Kao CS; Ellis C; Bonert M; Leroy X; Kunju LP; Schwartz L; Matsika A; Williamson SR; Rao P; Divatia M; Guarch R; Algaba F; Balancin ML; Zhou M; Samaratunga H; da Cunha IW; Brimo F; Ryan A; Clouston D; Aron M; O'Donnell M; Chan E; Hirsch MS; Moch H; Pang CY; Wah C; Yin W; Perry-Keene J; Yilmaz A; Chou A; Clarkson A; van der Westhuizen G; Morrison E; Zwi J; Hes O; Trpkov K; Gill AJ
Mod Pathol; 2022 Jun; 35(6):836-849. PubMed ID: 34949766
[TBL] [Abstract][Full Text] [Related]
28. SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery.
Saxena N; Maio N; Crooks DR; Ricketts CJ; Yang Y; Wei MH; Fan TW; Lane AN; Sourbier C; Singh A; Killian JK; Meltzer PS; Vocke CD; Rouault TA; Linehan WM
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26719882
[TBL] [Abstract][Full Text] [Related]
29. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.
Ricketts CJ; Shuch B; Vocke CD; Metwalli AR; Bratslavsky G; Middelton L; Yang Y; Wei MH; Pautler SE; Peterson J; Stolle CA; Zbar B; Merino MJ; Schmidt LS; Pinto PA; Srinivasan R; Pacak K; Linehan WM
J Urol; 2012 Dec; 188(6):2063-71. PubMed ID: 23083876
[TBL] [Abstract][Full Text] [Related]
30. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Yoo A; Tang C; Zucker M; Fitzgerald K; DiNatale RG; Rappold PM; Weiss K; Freeman B; Lee CH; Schultz N; Motzer R; Russo P; Coleman J; Reuter VE; Chen YB; Carlo MI; Gill AJ; Kotecha RR; Ari Hakimi A; Reznik E
Eur Urol Focus; 2022 Sep; 8(5):1278-1288. PubMed ID: 35288096
[TBL] [Abstract][Full Text] [Related]
31. SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response.
McEvoy CR; Koe L; Choong DY; Leong HS; Xu H; Karikios D; Plew JD; Prall OW; Fellowes AP; Fox SB
NPJ Precis Oncol; 2018; 2():9. PubMed ID: 29872718
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.
Kamai T; Higashi S; Murakami S; Arai K; Namatame T; Kijima T; Abe H; Jamiyan T; Ishida K; Shirataki H; Yoshida KI
Cancer Sci; 2021 Aug; 112(8):3375-3387. PubMed ID: 34014604
[TBL] [Abstract][Full Text] [Related]
33. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
34. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
35. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
Tsai TH; Lee WY
Arch Pathol Lab Med; 2019 May; 143(5):643-647. PubMed ID: 31026220
[TBL] [Abstract][Full Text] [Related]
36. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor With SDHC Germline Mutation and Bilateral Renal and Neck Cysts.
Stanley K; Friehling E; Davis A; Ranganathan S
Pediatr Dev Pathol; 2019; 22(3):265-268. PubMed ID: 30301441
[TBL] [Abstract][Full Text] [Related]
37. Genetic and epigenetic alterations of SDH genes in patients with sporadic succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Shi SS; Wang YF; Bao W; Ye SB; Wu N; Wang X; Xia QY; Li R; Shen Q; Zhou XJ
Pathol Int; 2019 Jun; 69(6):350-359. PubMed ID: 31273876
[TBL] [Abstract][Full Text] [Related]
38. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
[TBL] [Abstract][Full Text] [Related]
39. Succinate dehydrogenase B-deficient renal cell carcinoma with a germline variant in a Japanese patient: a case report.
Higashi S; Sasaki T; Uchida K; Kageyama T; Ikejiri M; Matsumoto R; Kato M; Masui S; Yoshio Y; Nishikawa K; Okugawa Y; Watanabe M; Inoue T
Hum Genome Var; 2022 Jul; 9(1):25. PubMed ID: 35869040
[TBL] [Abstract][Full Text] [Related]
40. Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.
Ueno D; Vasquez JC; Sule A; Liang J; van Doorn J; Sundaram R; Friedman S; Caliliw R; Ohtake S; Bao X; Li J; Ye H; Boyd K; Huang RR; Dodson J; Boutros P; Bindra RS; Shuch B
Oncotarget; 2022; 13():1054-1067. PubMed ID: 36128328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
